Zobrazeno 91 - 100
of 666
pro vyhledávání: '"392"'
Autor:
Sara Wirén, Tanja Stocks, Pär Stattin, Göran Hallmans, Anders Bergh, Sabina Rinaldi, Ulf-Håkan Stenman, Rudolf Kaaks
Publikováno v:
The Prostate. 67(11)
Androgens have been implicated in prostate tumorigenesis, but prospective studies have overall reported no association between circulating levels of androgens and risk of prostate cancer. However, some recent studies have shown that a high level of t
Autor:
Yoshiaki Tsuchida, Tatsuro Tajiri, Sachiyo Suita, Misako Hirai, Michio Kaneko, Toru Sugimoto, Hideo Mugishima
Publikováno v:
Journal of pediatric surgery. 42(3)
Background/Purpose This study aims to clarify the implications of MYCN amplification in patients with high-risk neuroblastomas treated with 2 different regimens of induction chemotherapy established by the Japan Study Group for Advanced Neuroblastoma
Autor:
Gang Wang, Yaoyi Xiong, Xuefeng Liu, Yongwen Luo, Lingao Ju, Yu Xiao, Liang Chen, Xinghuan Wang, Qiang Zhou
Publikováno v:
Journal of Cellular and Molecular Medicine
Cancer immune plays a critical role in cancer progression. Tumour immunology and immunotherapy are one of the exciting areas in bladder cancer research. In this study, we aimed to develop an immune‐related gene signature to improve the prognostic p
Autor:
Katsutoshi Sekine, Hideaki Kanki, Makoto Akaishi, Takashi Akima, Koki Yamaoka, Kazuaki Nakajima, Yuta Seki, Masahito Munakata, Takashi Koyama
Publikováno v:
Circulation Reports
Background: The relationship between left ventricular diastolic dysfunction (LVDD) and paroxysmal atrial fibrillation (PAF) remains unclear because of a lack of standard measures to evaluate LVDD. Accordingly, we examined the association between the
Autor:
Camilla Lagheden, Joakim Dillner, Karin Sundström, Laila Sara Arroyo Mühr, Sara Nordqvist Kleppe, Jiayao Lei, Pär Sparén, Carina Eklund
Publikováno v:
British Journal of Cancer
Background Human papillomavirus (HPV) is a necessary cause of cervical cancer, although some invasive cervical cancers may test negative by HPV PCR. We previously requested all invasive cervical cancers in Sweden during 10 years and subjected them to
Autor:
Jesper Eugen-Olsen, Morten Helms, Martin Schultz, Kim P David, Line Jee Hartmann Rasmussen, Andreas Kjaer, Kasper Iversen, Anne-Mette Lebech, Gitte Kronborg
Publikováno v:
Rasmussen, L J H, Schultz, M, Iversen, K, Eugen-Olsen, J, Helms, M, David, K, Kjaer, A, Lebech, A M & Kronborg, G 2020, ' Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancer ', Clinical Biochemistry, vol. 84, pp. 31-37 . https://doi.org/10.1016/j.clinbiochem.2020.06.001
Background: Accurate first-line diagnostics are essential for early recognition of cancer but also to identify patients free of disease. The biomarker soluble urokinase plasminogen activator receptor (suPAR) is elevated in patients with cancer or non
Publikováno v:
Clinical Endocrinology. 94:74-84
Objective: Polycystic ovary syndrome (PCOS) is associated with metabolic risk. Complement proteins regulate inflammation and lipid clearance but their role in PCOS‐associated metabolic risk is unclear. We sought to establish whether the complement
Autor:
Paul De Land, Milton M Hom
Publikováno v:
Optometry (St. Louis, Mo.). 77(11)
Purpose Dry eyes and diabetes have been linked in previous studies. However, the connection between a family history of diabetes and self-reported dry eyes needs to be explored. Patients with self-reported dry eyes were screened for self-reported dia
Publikováno v:
European journal of epidemiology. 20(10)
The authors assessed whether collection by mail of saliva and buccal cells for genetic analysis was feasible in participants recruited through the Internet. In 2003, 14,773 visitors of a smoking cessation website were invited by e-mail to take part i
Autor:
Kristin V. Carson-Chahhoud, Brian J. Smith, Matthew J. Peters, Malcolm P. Brinn, Faisal Ameer, Kuljit Singh, Robert Fitridge, John Litt, David Edwards, Simon A. Koblar, Jim Jannes, Antony J. Veale, Sharon Goldsworthy, Khin Hnin, Adrian J. Esterman
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 4, p e0231095 (2020)
PLoS ONE, Vol 15, Iss 4, p e0231095 (2020)
IntroductionVarenicline tartrate is superior for smoking cessation to other tobacco cessation therapies by 52 weeks, in the outpatient setting. We aimed to evaluate the long-term (104 week) efficacy following a standard course of inpatient-initiated